Literature DB >> 12093893

Increased C5a receptor expression in sepsis.

Niels C Riedemann1, Ren-Feng Guo, Thomas A Neff, Ines J Laudes, Katie A Keller, Vidya J Sarma, Maciej M Markiewski, Dimitrios Mastellos, Christoph W Strey, Carl L Pierson, John D Lambris, Firas S Zetoune, Peter A Ward.   

Abstract

Excessive production of the complement activation product C5a appears to be harmful during the development of sepsis in rodents. Little is known about the role of the C5a receptor (C5aR) and its presence in different organs during sepsis. Using the cecal ligation/puncture (CLP) model in mice, we show here that C5aR immunoreactivity was strikingly increased in lung, liver, kidney, and heart early in sepsis in both control and neutrophil-depleted mice. C5aR mRNA expression in these organs was also significantly increased during sepsis. Immunohistochemical analysis revealed patterns of increased C5aR expression in parenchymal cells in all four organs following CLP. Mice injected at the start of CLP with a blocking IgG to C5aR (alphaC5aR) showed dramatically improved survival when compared with animals receiving nonspecific IgG, as did mice injected with alphaC5a. In alphaC5aR-treated mice, serum levels of IL-6 and TNF-alpha and bacterial counts in various organs were significantly reduced during CLP when compared with control CLP animals. These studies demonstrate for the first time that C5aR is upregulated in lung, liver, kidney, and heart during the early phases of sepsis and that blockade of C5aR is highly protective from the lethal outcome of sepsis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12093893      PMCID: PMC151030          DOI: 10.1172/JCI15409

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  34 in total

1.  Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage.

Authors:  T Sacks; C F Moldow; P R Craddock; T K Bowers; H S Jacob
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

2.  Characterization of a receptor for C5a anaphylatoxin on human eosinophils.

Authors:  N P Gerard; M K Hodges; J M Drazen; P F Weller; C Gerard
Journal:  J Biol Chem       Date:  1989-01-25       Impact factor: 5.157

3.  Endotoxin-induced shock in the rat. A role for C5a.

Authors:  G Smedegård; L X Cui; T E Hugli
Journal:  Am J Pathol       Date:  1989-09       Impact factor: 4.307

4.  Chemotactic and anaphylatoxic fragment cleaved from the fifth component of guinea pig complement.

Authors:  H S Shin; R Snyderman; E Friedman; A Mellors; M M Mayer
Journal:  Science       Date:  1968-10-18       Impact factor: 47.728

5.  Generation of C5-derived lysosomal enzyme-releasing activity (C5a) by lysates of leukocyte lysosomes.

Authors:  I M Goldstein; G Weissmann
Journal:  J Immunol       Date:  1974-11       Impact factor: 5.422

6.  Identification of the C3b receptor-binding domain in third component of complement.

Authors:  J D Becherer; J D Lambris
Journal:  J Biol Chem       Date:  1988-10-05       Impact factor: 5.157

7.  Inhibition of immune-complex mediated dermal inflammation in rats following either oral or topical administration of a small molecule C5a receptor antagonist.

Authors:  A J Strachan; I A Shiels; R C Reid; D P Fairlie; S M Taylor
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

8.  Protective effects of anti-C5a peptide antibodies in experimental sepsis.

Authors:  M S Huber-Lang; J V Sarma; S R McGuire; K T Lu; R F Guo; V A Padgaonkar; E M Younkin; I J Laudes; N C Riedemann; J G Younger; P A Ward
Journal:  FASEB J       Date:  2001-01-19       Impact factor: 5.191

9.  Demonstration of specific C5a receptor on intact human polymorphonuclear leukocytes.

Authors:  D E Chenoweth; T E Hugli
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

10.  The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement.

Authors:  C G Cochrane; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1968-02-01       Impact factor: 14.307

View more
  70 in total

Review 1.  Is CaMKII a link between inflammation and hypertrophy in heart?

Authors:  Madhu V Singh; Mark E Anderson
Journal:  J Mol Med (Berl)       Date:  2011-01-29       Impact factor: 4.599

Review 2.  Complement-induced impairment of the innate immune system during sepsis.

Authors:  Eric A Albrecht; Peter A Ward
Journal:  Curr Allergy Asthma Rep       Date:  2004-09       Impact factor: 4.806

3.  C5a-induced gene expression in human umbilical vein endothelial cells.

Authors:  Eric A Albrecht; Arul M Chinnaiyan; Sooryanarayana Varambally; Chandan Kumar-Sinha; Terrence R Barrette; J Vidya Sarma; Peter A Ward
Journal:  Am J Pathol       Date:  2004-03       Impact factor: 4.307

Review 4.  Current and future concepts of abdominal sepsis.

Authors:  Klaus Emmanuel; Heike Weighardt; Holger Bartels; Jorg-Rudiger Siewert; Bernhard Holzmann
Journal:  World J Surg       Date:  2005-01       Impact factor: 3.352

Review 5.  Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management.

Authors:  Michael A Matthay; Guy A Zimmerman
Journal:  Am J Respir Cell Mol Biol       Date:  2005-10       Impact factor: 6.914

Review 6.  New insights into cellular mechanisms during sepsis.

Authors:  Laszlo M Hoesel; Hongwei Gao; Peter A Ward
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 7.  Sepsis, apoptosis and complement.

Authors:  P A Ward
Journal:  Biochem Pharmacol       Date:  2008-09-20       Impact factor: 5.858

8.  Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis.

Authors:  Rajesh K Thimmulappa; Hannah Lee; Tirumalai Rangasamy; Sekhar P Reddy; Masayuki Yamamoto; Thomas W Kensler; Shyam Biswal
Journal:  J Clin Invest       Date:  2006-04       Impact factor: 14.808

9.  Complement-induced Impairment of the Innate Immune System During Sepsis.

Authors:  Eric A Albrecht; Peter A Ward
Journal:  Curr Infect Dis Rep       Date:  2005-09       Impact factor: 3.725

10.  Complement mediates a primed inflammatory response after traumatic lung injury.

Authors:  J Jason Hoth; Jonathan D Wells; Sarah E Jones; Barbara K Yoza; Charles E McCall
Journal:  J Trauma Acute Care Surg       Date:  2014-03       Impact factor: 3.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.